title: [Psychotropic drugs for behavior disorder treatment in oligophrenic epileptics].
abstract: Forty-one patients were treated with promazine, a phenothiazine derivative, for an average of 266 days. The average daily dose was 200 mg. Thirty patients were treated with levomepromazine for an average of 115 days, the daily dose being about 130 mg. The two groups of patients were examined for their contactual, impulsive, and affective behavior before, during, and after treatment. The positive results obtained justify the use of the above-mentioned psychopharmaceuticals for the therapy of abnormal behavior of oligophrenic epileptics.
mesh_terms: D000328:Adult; D004827:Epilepsy / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008607:Intellectual Disability / Q000150:complications; D008728:Methotrimeprazine / Q000627:therapeutic use*; D010672:Phenytoin / Q000627:therapeutic use; D011324:Primidone / Q000627:therapeutic use; D011395:Promazine / Q000627:therapeutic use*; D012920:Social Behavior Disorders / Q000188:drug therapy* / Q000209:etiology
chemical_list: D011324:Primidone; D010672:Phenytoin; D008728:Methotrimeprazine; D011395:Promazine
vernacular_title: Psychopharmaka in der Therapie von Verhaltensauffälligkeiten bei oligophrenen Epileptikern